One of the largest drug maker Sun Pharmaceutical Industries achieved another milestone by recently acquiring a US-based injectable-product manufacturing and services company Pharmalucence.
One of the largest drug maker Sun Pharmaceutical Industries achieved another milestone by recently acquiring a US-based injectable-product manufacturing and services company Pharmalucence. No financial terms were disclosed with respect to the above acquisition. Few months back, Sun Pharma had announced a deal to buy Ranbaxy Laboratories from Japan's Diiachi Sankyo for $3.2 billion in shares. These acquisitions have scaled up the revenue for the drug maker to $2.7 billion for fiscal 2014.
Published On 18 July 2014
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.